The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia
Open accessAbstract
In an attempt to understand the applicability of various animal models to dyslipidemia in humans and to identify improved preclinical models for target discovery and validation for dyslipidemia, we measured comprehensive plasma lipid profiles in 24 models. These included five mouse strains, six other nonprimate species, and four nonhuman primate (NHP) species, and both healthy animals and animals with metabolic disorders. Dyslipidemic humans were assessed by the same measures. Plasma lipoprotein profiles, eight major plasma lipid fractions, and FA compositions within these lipid fractions were compared both qualitatively and quantitatively across the species. Given the importance of statins in decreasing plasma low-density lipoprotein cholesterol for treatment of dyslipidemia in humans, the responses of these measures to simvastatin treatment were also assessed for each species and compared with dyslipidemic humans. NHPs, followed by dog, were the models that demonstrated closest overall match to dyslipidemic humans. For the subset of the dyslipidemic population with high plasma triglyceride levels, the data also pointed to hamster and db/db mouse as representative models for practical use in target validation. Most traditional models, including rabbit, Zucker diabetic fatty rat, and the majority of mouse models, did not demonstrate overall similarity to dyslipidemic humans in this study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L. (1992) · Cell · doi:10.1016/0092-8674(92)90362-g · Cited by 2,263
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237
Collaborators, C. T. T. (. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60104-x · Cited by 2,081
Lipidomics reveals a remarkable diversity of lipids in human plasma
Quehenberger, O., Armando, A. M., Brown, A. H., Milne, S. B., Myers, D. S., Merrill, A. H., Bandyopadhyay, S., Jones, K. N., Kelly, S., Shaner, R. L., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m009449 · Cited by 1,341
A lipidomic analysis of nonalcoholic fatty liver disease
Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338
Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy
Cannon, C. P., Steinberg, B. A., Murphy, S. A., Mega, J. L., & Braunwald, E. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.04.070 · Cited by 770
Research works printed but not linked: 54
- Yusuf, 2001, Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization, Circulation., 104, 2746, 10.1161/hc4601.099487 · DOI · Paper page
- Paramsothy, 2006, Management of dyslipidaemias, Heart., 92, 1529, 10.1136/hrt.2005.071712 · DOI
- Sharma, 2009, Systemic review: comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia, Ann. Intern. Med., 151, 622, 10.7326/0003-4819-151-9-200911030-00144 · DOI · Paper page
- Cannon, 2008, Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes, Am. Heart J., 156, 826, 10.1016/j.ahj.2008.07.023 · DOI · Paper page
- Alagona, 2009, Beyond LDL cholesterol: the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy, Am. J. Manag. Care., 15, S65
- Russell, 2006, Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis, Cardiovasc. Pathol., 15, 318, 10.1016/j.carpath.2006.09.001 · DOI · Paper page
- Tsutsumi, 2001, The relationship between plasma high density lipoprotein cholesterol levels and cholesteryl ester transfer protein activity in six species of healthy experimental animals, Biol. Pharm. Bull., 24, 579, 10.1248/bpb.24.579 · DOI
- Ishibashi, 1993, Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery, J. Clin. Invest., 92, 883, 10.1172/JCI116663 · DOI · Paper page
- Harada, 2006, Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol, Clin. Exp. Pharmacol. Physiol., 33, 1209, 10.1111/j.1440-1681.2006.04512.x · doi:10.1111/j.1440-1681.2006.04512.x
- Van Eck, 2007, Important role for bone marrow-derived cholesteryl ester transfer protein in lipoprotein cholesterol redistribution and atherosclerotic lesion development in LDL receptor knockout mice, Circ. Res., 100, 678, 10.1161/01.RES.0000260202.79927.4f · DOI
- Kolodgie, 1996, Hypercholesterolemia in the rabbit induced by feeding graded amounts of low-level cholesterol. Methodological considerations regarding individual variability in response to dietary cholesterol and development of lesion type, Arterioscler. Thromb. Vasc. Biol., 16, 1454, 10.1161/01.ATV.16.12.1454 · DOI
- 2001, Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III), J. Am. Med. Assoc., 285, 2486, 10.1001/jama.285.19.2486 · DOI · Paper page
- Kontush, 2010, Lipidomics as a tool for the study of lipoprotein metabolism, Curr. Atheroscler. Rep., 12, 194, 10.1007/s11883-010-0100-0 · DOI
- Ekroos, 2010, Lipidomics: a tool for studies of atherosclerosis, Curr. Atheroscler. Rep., 12, 273, 10.1007/s11883-010-0110-y · DOI
- Chen, 2011, The effects of simvastatin treatment on plasma lipid-related biomarkers in men with dyslipidaemia, Biomarkers., 16, 321, 10.3109/1354750X.2011.561367 · DOI
- Bajpai, 2010, Should we measure C-reactive protein on earth or just on JUPITER?, Clin. Cardiol., 33, 190, 10.1002/clc.20681 · DOI
- 28., Genest, J., C-reactive protein: risk factor, biomarker and/or therapeutic target? Can. J. Cardiol. 26 (Suppl A): 41–44. · DOI
- Claus, 1976, Radioimmunoassay of human C-reactive protein and levels in normal sera, J. Lab. Clin. Med., 87, 120
- Tomassini, 2009, Effect of ezetimibe/simvastatin compared with atorvastatin on lipoprotein subclasses in patients with type 2 diabetes and hypercholesterolaemia, Diabetes Obes. Metab., 11, 855, 10.1111/j.1463-1326.2009.01061.x · DOI
- Cross, 2004, Saliva sampling to assess cortisol levels in unrestrained common marmosets and the effect of behavioral stress, Am. J. Primatol., 62, 107, 10.1002/ajp.20005 · DOI
- Harchaoui, 2009, Triglycerides and cardiovascular risk, Curr. Cardiol. Rev., 5, 216, 10.2174/157340309788970315 · DOI
- Grove, 1991, Comparative specificity of plasma lecithin:cholesterol acyltransferase from ten animal species, Lipids., 26, 416, 10.1007/BF02536066 · DOI
- Rousset, 2009, Lecithin:cholesterol acyltransferase–from biochemistry to role in cardiovascular disease, Curr. Opin. Endocrinol. Diabetes Obes., 16, 163, 10.1097/MED.0b013e328329233b · DOI · Paper page
- Chang, 2001, Roles of acyl-coenzyme A:cholesterol acyltransferase-1 and -2, Curr. Opin. Lipidol., 12, 289, 10.1097/00041433-200106000-00008 · DOI · Paper page
- Lee, 2004, Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential, Circ. Res., 95, 998, 10.1161/01.RES.0000147558.15554.67 · DOI · Paper page
- Cho, 1998, A peptide from hog plasma that inhibits human cholesteryl ester transfer protein, Biochim. Biophys. Acta., 1391, 133, 10.1016/S0005-2760(97)00197-5 · DOI
- Guyard-Dangremont, 1998, Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species. Relation to atherogenesis susceptibility, Comp. Biochem. Physiol. B Biochem. Mol. Biol., 120, 517, 10.1016/S0305-0491(98)10038-X · DOI
- Oliveira, 1996, J. Biol. Chem., 271, 31831, 10.1074/jbc.271.50.31831 · DOI
- Jiang, 1992, Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. Dependence on natural flanking sequences, J. Clin. Invest., 90, 1290, 10.1172/JCI115993 · DOI · Paper page
- Quinet, 1990, Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver, J. Clin. Invest., 85, 357, 10.1172/JCI114446 · DOI
- Gal, 1990, Atherosclerotic Yucatan microswine: an animal model with high-grade, fibrocalcific, nonfatty lesions suitable for testing catheter-based interventions, Am. Heart J., 119, 291, 10.1016/S0002-8703(05)80019-5 · doi:10.1016/s0002-8703(05)80019-5
- Dixon, 2002, Increased atherosclerosis in diabetic dyslipidemic swine: protection by atorvastatin involves decreased VLDL triglycerides but minimal effects on the lipoprotein profile, J. Lipid Res., 43, 1618, 10.1194/jlr.M200134-JLR200 · DOI
- Berkhout, 1997, SR-12813 lowers plasma cholesterol in beagle dogs by decreasing cholesterol biosynthesis, Atherosclerosis., 133, 203, 10.1016/S0021-9150(97)00131-7 · DOI
- Hough, 1975, Cholesterol kinetic analysis in normal and cholesterol-fed rabbits; effects of saturated versus polyunsaturated fat and of cholestyramine, J. Nutr., 105, 649, 10.1093/jn/105.6.649 · doi:10.1093/jn/105.6.649
- Clay, 1989, The rabbit as an animal model of hepatic lipase deficiency, Biochim. Biophys. Acta., 1002, 173, 10.1016/0005-2760(89)90284-1 · DOI
- Chang, 1993, Hepatic lipase function and the accumulation of beta-very-low-density lipoproteins in the plasma of cholesterol-fed rabbits, Biochem. J., 293, 745, 10.1042/bj2930745 · DOI
- Uelmen, 1995, Tissue-specific expression and cholesterol regulation of acylcoenzyme A:cholesterol acyltransferase (ACAT) in mice. Molecular cloning of mouse ACAT cDNA, chromosomal localization, and regulation of ACAT in vivo and in vitro, J. Biol. Chem., 270, 26192, 10.1074/jbc.270.44.26192 · DOI
- Downs, 1993, Plasma lipoprotein lipids in five different breeds of dogs, Res. Vet. Sci., 54, 63, 10.1016/0034-5288(93)90012-5 · DOI
- Tardif, 2009, Characterization of obese phenotypes in a small nonhuman primate, the common marmoset (Callithrix jacchus), Obesity (Silver Spring)., 17, 1499, 10.1038/oby.2009.77 · DOI
- Yang, 2009, Fenofibric acid: in combination therapy in the treatment of mixed dyslipidemia, Am. J. Cardiovasc. Drugs., 9, 401, 10.2165/11203920-000000000-00000 · DOI
- Serisier, 2006, Fenofibrate lowers lipid parameters in obese dogs, J. Nutr., 136, 2037, 10.1093/jn/136.7.2037S · DOI
- Srivastava, 2010, Anti-hyperlipidemic and insulin sensitizing activities of fenofibrate reduces aortic lipid deposition in hyperlipidemic Golden Syrian hamster, Mol. Cell. Biochem., 345, 197, 10.1007/s11010-010-0573-8 · DOI
- Krause, 1998, Lack of predictability of classical animal models for hypolipidemic activity: a good time for mice?, Atherosclerosis., 140, 15, 10.1016/S0021-9150(98)00141-5 · DOI
- Harris, 1996, n-3 fatty acids and lipoproteins: comparison of results from human and animal studies, Lipids., 31, 243, 10.1007/BF02529870 · DOI · Paper page
- Patel, 2009, Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy, Vasc. Health Risk Manag., 5, 801, 10.2147/VHRM.S4307 · DOI
- Lusis, 2000, Atherosclerosis, Nature., 407, 233, 10.1038/35025203 · DOI · Paper page
- Shi, 2009, Vulnerable plaque in a Swine model of carotid atherosclerosis, AJNR Am. J. Neuroradiol., 30, 469, 10.3174/ajnr.A1410 · doi:10.3174/ajnr.a1410
- Kagawa, 1998, Systemic atherosclerosis in dogs: histopathological and immunohistochemical studies of atherosclerotic lesions, J. Comp. Pathol., 118, 195, 10.1016/S0021-9975(05)80126-4 · doi:10.1016/s0021-9975(05)80126-4
- Dillard, 2010, Use of hamster as a model to study diet-induced atherosclerosis, Nutr. Metab. (Lond)., 7, 89, 10.1186/1743-7075-7-89 · DOI
- Lands, 1960, Metabolism of glycerolipids. II. The enzymatic acylation of lysolecithin, J. Biol. Chem., 235, 2233, 10.1016/S0021-9258(18)64604-6 · DOI · Paper page
- Lands, 1963, Metabolism of glycerolipids. III. Reactivity of various acyl esters of coenzyme A with alpha’-acylglycerophosphorylcholine, and positional specificities in lecithin synthesis, J. Biol. Chem., 238, 898, 10.1016/S0021-9258(18)81234-0 · DOI · Paper page
- Jezyk, 1968, Specificity of acyl-CoA: phospholipid acyltransferases: solvent and temperature effects, J. Lipid Res., 9, 525, 10.1016/S0022-2275(20)42733-6 · doi:10.1016/s0022-2275(20)42733-6
- Abd, 2011, The role of C-reactive protein as a risk predictor of coronary atherosclerosis: implications from the JUPITER trial, Curr. Atheroscler. Rep., 13, 154, 10.1007/s11883-011-0164-5 · DOI
- Jinbo, 1998, Development of monkey C-reactive protein (CRP) assay methods, Vet. Immunol. Immunopathol., 61, 195, 10.1016/S0165-2427(97)00148-7 · doi:10.1016/s0165-2427(97)00148-7
Cited by
Drug delivery systems for RNA therapeutics
Paunovska, K., Loughrey, D., & Dahlman, J. E. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-021-00439-4 · Cited by 1,349
How the immune system shapes atherosclerosis: roles of innate and adaptive immunity
Roy, P., Orecchioni, M., & Ley, K. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00584-1 · Cited by 565
Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease
Dewey, F. E., Gusarova, V., O’Dushlaine, C., Gottesman, O., Trejos, J., Hunt, C., Van Hout, C. V., Habegger, L., Buckler, D., Lai, K.-M. V., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1510926 · Cited by 497
Soft Drusen in Age-Related Macular Degeneration: Biology and Targeting Via the Oil Spill Strategies
Curcio, C. A. (2018) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.18-24882 · Cited by 318
A new perspective on lipid research in age-related macular degeneration
van Leeuwen, E. M., Emri, E., Merle, B. M. J., Colijn, J. M., Kersten, E., Cougnard-Gregoire, A., Dammeier, S., Meester-Smoor, M., Pool, F. M., de Jong, E. K., et al. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.04.006 · Cited by 247
Metadata
- Authors
- Yin, W., Carballo-Jane, E., McLaren, D. G., Mendoza, V. H., Gagen, K., Geoghagen, N. S., McNamara, L. A., Gorski, J. N., Eiermann, G. J., Petrov, A., Wolff, M., Tong, X., Wilsie, L. C., Akiyama, T. E., Chen, J., Thankappan, A., Xue, J., Ping, X., Andrews, G., Wickham, L. A., Gai, C. L., Trinh, T., Kulick, A. A., Donnelly, M. J., Voronin, G. O., Rosa, R., Cumiskey, A.-M., Bekkari, K., Mitnaul, L. J., Puig, O., Chen, F., Raubertas, R., Wong, P. H., Hansen, B. C., Koblan, K. S., Roddy, T. P., Hubbard, B. K., & Strack, A. M.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 53
- Issue
- 1
- Pages
- 51-65
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W2111563461
- Cited by
- 218
- References
- 14
- FWCI
- 7.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 3207 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. https://app.cochat.ai/papers/10.1194/jlr.m019927
- The paper
- Yin, W., Carballo-Jane, E., McLaren, D. G., Mendoza, V. H., Gagen, K., Geoghagen, N. S., McNamara, L. A., Gorski, J. N., Eiermann, G. J., Petrov, A., Wolff, M., Tong, X., Wilsie, L. C., Akiyama, T. E., Chen, J., Thankappan, A., Xue, J., Ping, X., Andrews, G., . . . Strack, A. M. (2012). Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. Journal of Lipid Research. https://doi.org/10.1194/jlr.m019927
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.